Kevin D. Freeman - Jul 17, 2025 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Stock symbol
GALT
Transactions as of
Jul 17, 2025
Transactions value $
$14,495
Form type
4
Date filed
7/18/2025, 10:38 AM
Previous filing
Jan 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FREEMAN KEVIN D Director C/O GALECTIN THERAPEUTICS INC., 4960 PEACHTREE INDUSTRIAL BLVD., STE 240, NORCROSS Jack W. Callicutt, by power of attorney 2025-07-18 0001522478

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Purchase $14.5K +5K +11.17% $2.90 49.8K Jul 17, 2025 Direct
holding GALT Common Stock 80K Jul 17, 2025 By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC F1
holding GALT Common Stock 18.1K Jul 17, 2025 IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.